ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Insulin Lispro Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19D10090
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Insulin Lispro Injection Market Insights Forecast to 2028
BUY CHAPTERS

Global Recombinant Insulin Lispro Injection Market Research Report 2025

Code: QYRE-Auto-19D10090
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GT
Tonghua Dongbao Pharmaceutical
Eli Lilly and Company
Novo Nordisk
Pfizer Inc
Sanofi
Takeda Pharmaceutical Company
Wanbang Biopharmaceuticals
United Laboratories
BI

Recombinant Insulin Lispro Injection Market

The global market for Recombinant Insulin Lispro Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination technology. It is produced by exchanging the 28th and 29th amino acids on the insulin B chain. It is suitable for the need for insulin Adult diabetic patients who maintain euglycemic homeostasis
North American market for Recombinant Insulin Lispro Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Insulin Lispro Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Insulin Lispro Injection include GT, Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Novo Nordisk, Pfizer, BI, Sanofi, Takeda Pharmaceutical Company, Wanbang Biopharmaceuticals, United Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Insulin Lispro Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Insulin Lispro Injection.
The Recombinant Insulin Lispro Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Insulin Lispro Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Insulin Lispro Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Insulin Lispro Injection Market Report

Report Metric Details
Report Name Recombinant Insulin Lispro Injection Market
Segment by Type
  • 1ML
  • 3ML
  • 10ML
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GT, Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Novo Nordisk, Pfizer, BI, Sanofi, Takeda Pharmaceutical Company, Wanbang Biopharmaceuticals, United Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Insulin Lispro Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Insulin Lispro Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Insulin Lispro Injection Market report?

Ans: The main players in the Recombinant Insulin Lispro Injection Market are GT, Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Novo Nordisk, Pfizer, BI, Sanofi, Takeda Pharmaceutical Company, Wanbang Biopharmaceuticals, United Laboratories

What are the Application segmentation covered in the Recombinant Insulin Lispro Injection Market report?

Ans: The Applications covered in the Recombinant Insulin Lispro Injection Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Recombinant Insulin Lispro Injection Market report?

Ans: The Types covered in the Recombinant Insulin Lispro Injection Market report are 1ML, 3ML, 10ML

1 Recombinant Insulin Lispro Injection Market Overview
1.1 Product Definition
1.2 Recombinant Insulin Lispro Injection by Type
1.2.1 Global Recombinant Insulin Lispro Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 1ML
1.2.3 3ML
1.2.4 10ML
1.3 Recombinant Insulin Lispro Injection by Application
1.3.1 Global Recombinant Insulin Lispro Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Recombinant Insulin Lispro Injection Market Size Estimates and Forecasts
1.4.1 Global Recombinant Insulin Lispro Injection Revenue 2020-2031
1.4.2 Global Recombinant Insulin Lispro Injection Sales 2020-2031
1.4.3 Global Recombinant Insulin Lispro Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Insulin Lispro Injection Market Competition by Manufacturers
2.1 Global Recombinant Insulin Lispro Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Insulin Lispro Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Insulin Lispro Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Insulin Lispro Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Insulin Lispro Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Insulin Lispro Injection, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Insulin Lispro Injection, Date of Enter into This Industry
2.8 Global Recombinant Insulin Lispro Injection Market Competitive Situation and Trends
2.8.1 Global Recombinant Insulin Lispro Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Insulin Lispro Injection Players Market Share by Revenue
2.8.3 Global Recombinant Insulin Lispro Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Insulin Lispro Injection Market Scenario by Region
3.1 Global Recombinant Insulin Lispro Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Insulin Lispro Injection Sales by Region: 2020-2031
3.2.1 Global Recombinant Insulin Lispro Injection Sales by Region: 2020-2025
3.2.2 Global Recombinant Insulin Lispro Injection Sales by Region: 2026-2031
3.3 Global Recombinant Insulin Lispro Injection Revenue by Region: 2020-2031
3.3.1 Global Recombinant Insulin Lispro Injection Revenue by Region: 2020-2025
3.3.2 Global Recombinant Insulin Lispro Injection Revenue by Region: 2026-2031
3.4 North America Recombinant Insulin Lispro Injection Market Facts & Figures by Country
3.4.1 North America Recombinant Insulin Lispro Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Insulin Lispro Injection Sales by Country (2020-2031)
3.4.3 North America Recombinant Insulin Lispro Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Insulin Lispro Injection Market Facts & Figures by Country
3.5.1 Europe Recombinant Insulin Lispro Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Insulin Lispro Injection Sales by Country (2020-2031)
3.5.3 Europe Recombinant Insulin Lispro Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Insulin Lispro Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Insulin Lispro Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Insulin Lispro Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Insulin Lispro Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Insulin Lispro Injection Market Facts & Figures by Country
3.7.1 Latin America Recombinant Insulin Lispro Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Insulin Lispro Injection Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Insulin Lispro Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Insulin Lispro Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Insulin Lispro Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Insulin Lispro Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Insulin Lispro Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Insulin Lispro Injection Sales by Type (2020-2031)
4.1.1 Global Recombinant Insulin Lispro Injection Sales by Type (2020-2025)
4.1.2 Global Recombinant Insulin Lispro Injection Sales by Type (2026-2031)
4.1.3 Global Recombinant Insulin Lispro Injection Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Insulin Lispro Injection Revenue by Type (2020-2031)
4.2.1 Global Recombinant Insulin Lispro Injection Revenue by Type (2020-2025)
4.2.2 Global Recombinant Insulin Lispro Injection Revenue by Type (2026-2031)
4.2.3 Global Recombinant Insulin Lispro Injection Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Insulin Lispro Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Insulin Lispro Injection Sales by Application (2020-2031)
5.1.1 Global Recombinant Insulin Lispro Injection Sales by Application (2020-2025)
5.1.2 Global Recombinant Insulin Lispro Injection Sales by Application (2026-2031)
5.1.3 Global Recombinant Insulin Lispro Injection Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Insulin Lispro Injection Revenue by Application (2020-2031)
5.2.1 Global Recombinant Insulin Lispro Injection Revenue by Application (2020-2025)
5.2.2 Global Recombinant Insulin Lispro Injection Revenue by Application (2026-2031)
5.2.3 Global Recombinant Insulin Lispro Injection Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Insulin Lispro Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GT
6.1.1 GT Company Information
6.1.2 GT Description and Business Overview
6.1.3 GT Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GT Recombinant Insulin Lispro Injection Product Portfolio
6.1.5 GT Recent Developments/Updates
6.2 Tonghua Dongbao Pharmaceutical
6.2.1 Tonghua Dongbao Pharmaceutical Company Information
6.2.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.2.3 Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Product Portfolio
6.2.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Company Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly and Company Recombinant Insulin Lispro Injection Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Company Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novo Nordisk Recombinant Insulin Lispro Injection Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Recombinant Insulin Lispro Injection Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 BI
6.6.1 BI Company Information
6.6.2 BI Description and Business Overview
6.6.3 BI Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BI Recombinant Insulin Lispro Injection Product Portfolio
6.6.5 BI Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Recombinant Insulin Lispro Injection Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Takeda Pharmaceutical Company
6.8.1 Takeda Pharmaceutical Company Company Information
6.8.2 Takeda Pharmaceutical Company Description and Business Overview
6.8.3 Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Product Portfolio
6.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.9 Wanbang Biopharmaceuticals
6.9.1 Wanbang Biopharmaceuticals Company Information
6.9.2 Wanbang Biopharmaceuticals Description and Business Overview
6.9.3 Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Product Portfolio
6.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.10 United Laboratories
6.10.1 United Laboratories Company Information
6.10.2 United Laboratories Description and Business Overview
6.10.3 United Laboratories Recombinant Insulin Lispro Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 United Laboratories Recombinant Insulin Lispro Injection Product Portfolio
6.10.5 United Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Insulin Lispro Injection Industry Chain Analysis
7.2 Recombinant Insulin Lispro Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Insulin Lispro Injection Production Mode & Process Analysis
7.4 Recombinant Insulin Lispro Injection Sales and Marketing
7.4.1 Recombinant Insulin Lispro Injection Sales Channels
7.4.2 Recombinant Insulin Lispro Injection Distributors
7.5 Recombinant Insulin Lispro Injection Customer Analysis
8 Recombinant Insulin Lispro Injection Market Dynamics
8.1 Recombinant Insulin Lispro Injection Industry Trends
8.2 Recombinant Insulin Lispro Injection Market Drivers
8.3 Recombinant Insulin Lispro Injection Market Challenges
8.4 Recombinant Insulin Lispro Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GT
Tonghua Dongbao Pharmaceutical
Eli Lilly and Company
Novo Nordisk
Pfizer Inc
Sanofi
Takeda Pharmaceutical Company
Wanbang Biopharmaceuticals
United Laboratories
BI
List of Tables
 Table 1. Global Recombinant Insulin Lispro Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Insulin Lispro Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Insulin Lispro Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Insulin Lispro Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Insulin Lispro Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Insulin Lispro Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Insulin Lispro Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Insulin Lispro Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Insulin Lispro Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Insulin Lispro Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Insulin Lispro Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Insulin Lispro Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Insulin Lispro Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Insulin Lispro Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Insulin Lispro Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Insulin Lispro Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Insulin Lispro Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Insulin Lispro Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Insulin Lispro Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Insulin Lispro Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Insulin Lispro Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Insulin Lispro Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Insulin Lispro Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Insulin Lispro Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Insulin Lispro Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Insulin Lispro Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Insulin Lispro Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Insulin Lispro Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Insulin Lispro Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Insulin Lispro Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Insulin Lispro Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Insulin Lispro Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Insulin Lispro Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Insulin Lispro Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Insulin Lispro Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Insulin Lispro Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Insulin Lispro Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Insulin Lispro Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Insulin Lispro Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Insulin Lispro Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Insulin Lispro Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Insulin Lispro Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Insulin Lispro Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Insulin Lispro Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Insulin Lispro Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Insulin Lispro Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Insulin Lispro Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Insulin Lispro Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Insulin Lispro Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Insulin Lispro Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Insulin Lispro Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Insulin Lispro Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Insulin Lispro Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Insulin Lispro Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Insulin Lispro Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Insulin Lispro Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Insulin Lispro Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Insulin Lispro Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Insulin Lispro Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Insulin Lispro Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Insulin Lispro Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Insulin Lispro Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Insulin Lispro Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Insulin Lispro Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Insulin Lispro Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Insulin Lispro Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Insulin Lispro Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Insulin Lispro Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. GT Company Information
 Table 71. GT Description and Business Overview
 Table 72. GT Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GT Recombinant Insulin Lispro Injection Product
 Table 74. GT Recent Developments/Updates
 Table 75. Tonghua Dongbao Pharmaceutical Company Information
 Table 76. Tonghua Dongbao Pharmaceutical Description and Business Overview
 Table 77. Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Product
 Table 79. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
 Table 80. Eli Lilly and Company Company Information
 Table 81. Eli Lilly and Company Description and Business Overview
 Table 82. Eli Lilly and Company Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lilly and Company Recombinant Insulin Lispro Injection Product
 Table 84. Eli Lilly and Company Recent Developments/Updates
 Table 85. Novo Nordisk Company Information
 Table 86. Novo Nordisk Description and Business Overview
 Table 87. Novo Nordisk Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novo Nordisk Recombinant Insulin Lispro Injection Product
 Table 89. Novo Nordisk Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Recombinant Insulin Lispro Injection Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. BI Company Information
 Table 96. BI Description and Business Overview
 Table 97. BI Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BI Recombinant Insulin Lispro Injection Product
 Table 99. BI Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sanofi Recombinant Insulin Lispro Injection Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Takeda Pharmaceutical Company Company Information
 Table 106. Takeda Pharmaceutical Company Description and Business Overview
 Table 107. Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Product
 Table 109. Takeda Pharmaceutical Company Recent Developments/Updates
 Table 110. Wanbang Biopharmaceuticals Company Information
 Table 111. Wanbang Biopharmaceuticals Description and Business Overview
 Table 112. Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Product
 Table 114. Wanbang Biopharmaceuticals Recent Developments/Updates
 Table 115. United Laboratories Company Information
 Table 116. United Laboratories Description and Business Overview
 Table 117. United Laboratories Recombinant Insulin Lispro Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. United Laboratories Recombinant Insulin Lispro Injection Product
 Table 119. United Laboratories Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Recombinant Insulin Lispro Injection Distributors List
 Table 123. Recombinant Insulin Lispro Injection Customers List
 Table 124. Recombinant Insulin Lispro Injection Market Trends
 Table 125. Recombinant Insulin Lispro Injection Market Drivers
 Table 126. Recombinant Insulin Lispro Injection Market Challenges
 Table 127. Recombinant Insulin Lispro Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Insulin Lispro Injection
 Figure 2. Global Recombinant Insulin Lispro Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Insulin Lispro Injection Market Share by Type: 2024 & 2031
 Figure 4. 1ML Product Picture
 Figure 5. 3ML Product Picture
 Figure 6. 10ML Product Picture
 Figure 7. Global Recombinant Insulin Lispro Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Recombinant Insulin Lispro Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Pharmacy
 Figure 11. Global Recombinant Insulin Lispro Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Insulin Lispro Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Insulin Lispro Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Insulin Lispro Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Insulin Lispro Injection Report Years Considered
 Figure 16. Recombinant Insulin Lispro Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Insulin Lispro Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Insulin Lispro Injection Players: Market Share by Revenue in Recombinant Insulin Lispro Injection in 2024
 Figure 19. Recombinant Insulin Lispro Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Insulin Lispro Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Insulin Lispro Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Insulin Lispro Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Insulin Lispro Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Insulin Lispro Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Insulin Lispro Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Insulin Lispro Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Insulin Lispro Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Insulin Lispro Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Recombinant Insulin Lispro Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Insulin Lispro Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Recombinant Insulin Lispro Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Recombinant Insulin Lispro Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Insulin Lispro Injection by Type (2020-2031)
 Figure 55. Global Recombinant Insulin Lispro Injection Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Recombinant Insulin Lispro Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Recombinant Insulin Lispro Injection by Application (2020-2031)
 Figure 58. Global Recombinant Insulin Lispro Injection Price (US$/Unit) by Application (2020-2031)
 Figure 59. Recombinant Insulin Lispro Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Insulin Lispro Market Research Report 2024
Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Mixed Recombinant Human Insulin Injection Market Research Report 2024
Biosimilar Insulin Lispro Market
Global Premixed Insulin Analogs Market Research Report 2024
Global Human Recombinant Insulin Market Research Report 2024
Global Recombinant Insulin Analogue Market Research Report 2024
Global Insulin Detemir Injection Market Research Report 2024
Global Insulin Injection Equipment Market Research Report 2025
Global Insulin Injection Devices Market Research Report 2024
Insulin Injection Related Product Market
Global Insulin Injection Consumables Market Research Report 2025
Biosimilar Insulin Market
Global Human Insulin Delivery System Market Insights Forecast to 2030
Global Human Insulin Market Research Report 2024
Global Insulin Glulisine Injection Market Research Report 2024
Global Human Insulin Injections Market Research Report 2024
Global Insulin Glargine and Lispro Market Research Report 2024
Disposable Insulin Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Pen Injectors Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions